ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $215,519 | -40.4% | 3,712 | -44.7% | 0.00% | – |
Q2 2023 | $361,577 | +150.6% | 6,717 | +84.9% | 0.00% | – |
Q1 2023 | $144,302 | +289.9% | 3,633 | +294.9% | 0.00% | – |
Q4 2022 | $37,011 | -9.7% | 920 | -29.2% | 0.00% | – |
Q3 2022 | $41,000 | -46.1% | 1,300 | -49.6% | 0.00% | – |
Q2 2022 | $76,000 | -67.4% | 2,580 | -68.8% | 0.00% | – |
Q1 2022 | $233,000 | -74.3% | 8,275 | -57.9% | 0.00% | – |
Q4 2021 | $907,000 | +58.8% | 19,668 | +13.0% | 0.00% | – |
Q3 2021 | $571,000 | -23.4% | 17,404 | -18.2% | 0.00% | – |
Q2 2021 | $745,000 | -21.7% | 21,269 | -19.3% | 0.00% | – |
Q1 2021 | $952,000 | -8.0% | 26,361 | -26.1% | 0.00% | – |
Q4 2020 | $1,035,000 | -28.8% | 35,664 | -30.7% | 0.00% | – |
Q3 2020 | $1,454,000 | -15.8% | 51,500 | -3.5% | 0.00% | -100.0% |
Q2 2020 | $1,727,000 | +19.2% | 53,387 | +50.1% | 0.00% | 0.0% |
Q1 2020 | $1,449,000 | -72.8% | 35,571 | -58.8% | 0.00% | 0.0% |
Q4 2019 | $5,330,000 | -35.6% | 86,428 | -23.9% | 0.00% | -50.0% |
Q3 2019 | $8,274,000 | +68.6% | 113,538 | +90.3% | 0.00% | +100.0% |
Q2 2019 | $4,907,000 | +110.5% | 59,678 | +80.6% | 0.00% | 0.0% |
Q1 2019 | $2,331,000 | +73.3% | 33,039 | +10.5% | 0.00% | – |
Q4 2018 | $1,345,000 | -21.8% | 29,887 | -1.7% | 0.00% | – |
Q3 2018 | $1,719,000 | +55.7% | 30,392 | +84.0% | 0.00% | – |
Q2 2018 | $1,104,000 | +37.8% | 16,515 | +19.9% | 0.00% | – |
Q1 2018 | $801,000 | -8.6% | 13,774 | +1.4% | 0.00% | – |
Q4 2017 | $876,000 | +49.0% | 13,588 | +21.2% | 0.00% | – |
Q3 2017 | $588,000 | -21.8% | 11,215 | -30.2% | 0.00% | – |
Q2 2017 | $752,000 | +72.1% | 16,058 | +81.8% | 0.00% | – |
Q1 2017 | $437,000 | -56.1% | 8,832 | -46.2% | 0.00% | – |
Q4 2016 | $995,000 | +80.6% | 16,416 | +97.8% | 0.00% | – |
Q3 2016 | $551,000 | +90.0% | 8,298 | +59.4% | 0.00% | – |
Q2 2016 | $290,000 | -20.5% | 5,206 | -52.1% | 0.00% | – |
Q1 2016 | $365,000 | 0.0% | 10,871 | +34.2% | 0.00% | – |
Q4 2015 | $365,000 | -96.1% | 8,098 | -96.6% | 0.00% | -100.0% |
Q3 2015 | $9,320,000 | -32.2% | 235,894 | +6.5% | 0.00% | -20.0% |
Q2 2015 | $13,743,000 | -53.7% | 221,500 | -53.4% | 0.01% | -16.7% |
Q1 2015 | $29,704,000 | +58.7% | 474,904 | +43.1% | 0.01% | -14.3% |
Q4 2014 | $18,714,000 | +173.9% | 331,864 | +37.4% | 0.01% | +133.3% |
Q3 2014 | $6,833,000 | +42.2% | 241,606 | +73.1% | 0.00% | +50.0% |
Q2 2014 | $4,806,000 | +5690.4% | 139,544 | +5173.8% | 0.00% | – |
Q1 2014 | $83,000 | – | 2,646 | +88100.0% | 0.00% | – |
Q3 2013 | $0 | – | 3 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |